DekaBank Deutsche Girozentrale
FLNA

DekaBank Deutsche Girozentrale’s Filana Therapeutics FLNA Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-3,671
Closed -$119K – 984
2013
Q4 		$119K Buy
3,671
+71
+2% +$1.89K ﹤0.01% 719
2013
Q3 		$69K Buy
+3,600
New +$62.9K ﹤0.01% 761

Other funds holding FLNA

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
MSP
Madison Street Partners Denver, Colorado $3.05M AUM 5.94% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

DekaBank Deutsche Girozentrale's FLNA Position: Q1 2014 in Review

DekaBank Deutsche Girozentrale sold out of Filana Therapeutics (FLNA) in Q1 2014, closing a stake of 3,671 shares — an estimated $119K sold.

DekaBank Deutsche Girozentrale first reported a position in FLNA in Q3 2013 and held it in 2 quarters. The position peaked at $119K in Q4 2013. 75 funds tracked by Wall St. Rank hold FLNA as of Q1 2014.

  • DekaBank Deutsche Girozentrale reported no remaining Filana Therapeutics position as of Q1 2014 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 3,671 Filana Therapeutics shares in Q1 2014, an estimated $119K.
  • DekaBank Deutsche Girozentrale first reported a position in Filana Therapeutics in Q3 2013 and held it in 2 quarters.
  • DekaBank Deutsche Girozentrale's Filana Therapeutics position peaked at $119K in Q4 2013.
  • 75 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2014.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2014, filed 15 May 2014.